Hangzhou, China - Recently, MicroPort® Orthopedics attended the 11th Annual Meeting of Chinese Association of Orthpaedic Surgeons ("CAOS 2018") that focused on industries of joint, spine, trauma, and sport medicine. Several orthopedic experts specialized in minimally invasive technology were invited to discuss the development of minimally invasive technology as well as share their experience in minimally invasive surgeries. MicroPort® Orthopedics displayed its joint, spine and trauma product lines to demonstrate its branding ideology that "the Patient Always Comes First".
In this conference, MicroPort® Orthopedics displayed its Medial Pivot knee system, which caught wide attention from the attendees with its unique design. MicroPort® Orthopedics Medial Pivot knee was launched in the US in 1998 with around 20 years' clinical history. Up to date, nearly 600,000 Medial Pivot knees have been implanted globally. The Knee has published a study evaluating long-term clinical and radiographic outcomes of the Medial-Pivot Knee System. The results demonstrate excellent clinical outcomes for both satisfaction (95%) and survivorship (98.8%) at 17 years. MicroPort® Orthopedics SuperPath® Micro-posterior Total Hip Arthroplasty ("SuperPath®") also draw public attention with its "full function, faster" feature. As the world's first total hip arthroplasty minimally invasive technique that facilitates a faster return to function for patients, SuperPath® causes incision as little as a 3-inch and ensures the maximum protection of soft tissue, leading to fewer post-operative restrictions, faster return to function, and improved satisfaction for patients. Patients can walk as early as four hours after surgery. Recently a 103-year-old patient successfully received SuperPath® surgery in Zhengjiang First People's Hospital, which helped him to stand on his own feet the same day after the surgery. He is the oldest patient to be effectively treated by SuperPath® surgery in China.
MicroPort® Orthopedics also displayed its spine and trauma products including Wiltrom Spinal Fixation System ("Wiltrom") and Bicera Bone Graft Substitute in its booth. Wiltrom attracted wide attention with its unique guiding pin and guiding instruments. Through interpretations and demonstrations, MicroPort® Orthopedics showcased the advantages of Wiltrom. Some experts spoke highly of the delicate design of Wiltrom, as its matching instrument and sleeves can meet various clinical needs and optimize surgical incision, offering better solution for patients. Meanwhile, MicroPort® Orthopedics also showcased Piscis™ Lumbar & Thoracic Fusion Device, Takin™ Spinal Posterior Fixation System, and Bicera Bone Graft Substitute to visitors, to demonstrate its excellent product offering and lay a solid foundation for future market development.
During the conference, several senior orthopedic experts, including Professor Yan Wang of Chinese PLA General Hospital, visited MicroPort® Orthopedics booth and had in depth discussion with MicroPort® COO Glendy Wang and President of MicroPort® Orthopedics China Zixin Weng regarding product R&D and market development. MicroPort® Orthopedics will continue to take advantage of such conferences to enhance the communication with physicians and keep improving its products based on their clinical needs, and thereby benefit more surgeons and patients.
About MicroPort®
MicroPort Scientific Corporation (the "Group") is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 12 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Cardiac Rhythm Management, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort® is dedicated to becoming a patient oriented global enterprise improve and reshape patient lives through application of innovative science and technology.
For more information, please refer to: www.microport.com
Forward-Looking Statements
Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words "believe", "intend", "expect", anticipate", "project", "estimate", "predict", "is confident", "has confidence" and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort®'s management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.
This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.
All rights reserved.
Copyright © 1998-2018 MicroPort Scientific Corporation
Source: http://www.microport.com